eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | hypertriglyceridemia |
| Comorbidity | C0011860|type 2 diabetes |
| Sentences | 12 |
| PubMedID- 24876549 | Saroglitazar appeared to be an effective and safe therapeutic option for improving hypertriglyceridemia in patients with type 2 diabetes mellitus. |
| PubMedID- 21510110 | Post-prandial hypertriglyceridemia in patients with type 2 diabetes mellitus with and without macrovascular disease. |
| PubMedID- 25617537 | This literature review discusses the safety on glucose metabolism of n-3 pufa supplementation in the treatment of hypertriglyceridemia in subjects with type 2 diabetes mellitus. |
| PubMedID- 23853615 | Raised tg levels, small low density lipoprotein-cholesterol (ldl-c) particles, and low hdl-c (22)); low hdl-c was a component of mets only in the presence of hypertriglyceridemia in patients with type 2 diabetes mellitus (10). |
| PubMedID- 20398338 | Conclusion: the nile rat fed typical rodent diets develops hyperinsulinemia that precedes hyperglycemia (insulin resistance) leading to diet-induced type 2 diabetes associated with hypertriglyceridemia, hypercholesterolemia, and hypertension. |
| PubMedID- 25573251 | Saroglitazar appeared to be an effective and safe therapeutic option for improving hypertriglyceridaemia in patients with type 2 diabetes mellitus20. |
| PubMedID- 25725623 | The characteristic hypertriglyceridaemia observed in patients with type 2 diabetes stimulates cetp, leading to the preferential formation of triacylglycerol-rich small, dense ldl particles over larger ones [74]. |
| PubMedID- 23417910 | Severe hypertriglyceridaemia in type 2 diabetes mellitus: beneficial effect of continuous insulin infusion. |
| PubMedID- 22224930 | Even though insulin resistance, cardiovascular disease (cvd), and type 2 diabetes (t2d) are associated with hypertriglyceridemia, blacks with these conditions usually have normal triglyceride (tg) levels. |
| PubMedID- 21559242 | They exhibit an abnormal hyaluronic acid excretion, premature visceral obesity, hypertriglyceridemia, insulin-resistant type 2 diabetes and associated cardiovascular diseases, higher ros levels in several tissues, increased genomic instability, and cancer incidence resulting in a 10–15% decreased mean life span [128]. |
| PubMedID- 26291068 | Decreased vldl-apo b 100 fractional synthesis rate despite hypertriglyceridemia in subjects with type 2 diabetes and nephropathy. |
| PubMedID- 21532777 | A survey conducted in >8000 patients receiving treatment for dyslipidaemia, (mostly with a statin) in 11 european countries confirmed a higher prevalence of low hdl-c and/or hypertriglyceridaemia in patients with type 2 diabetes, relative to patients without diabetes (table 1) [13, 14]. |
Page: 1